HLS Therapeutics Inc. (TSE:HLS – Get Free Report) fell 0.2% during trading on Monday . The company traded as low as C$4.35 and last traded at C$4.49. 5,715 shares changed hands during trading, a decline of 46% from the average session volume of 10,544 shares. The stock had previously closed at C$4.50.
HLS Therapeutics Trading Down 0.2%
The firm has a 50-day simple moving average of C$4.61 and a 200-day simple moving average of C$5.06. The company has a quick ratio of 1.01, a current ratio of 1.17 and a debt-to-equity ratio of 87.61. The stock has a market cap of C$137.29 million, a PE ratio of -9.76 and a beta of 0.54.
About HLS Therapeutics
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue.
See Also
- Five stocks we like better than HLS Therapeutics
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- June 30th. The deadline Congress buried on page 847.
- 3 Signs You May Want to Switch Financial Advisors
- Your name isn’t on our protected list yet
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
